Blocking STAT3 activation by specific inhibitors effectively suppresses globular tumor formation and reduces the number of ALDH CD44 cells, and further induces apoptosis in HNSCC [68]. This evidence concerns the gene STAT3 and head and neck squamous cell carcinoma.